Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort studyCraig Haifer, Lena Thin, Daniel R. van Langenberg et al.|The Medical Journal of Australia|2020Cited by 22
Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort studyCraig Haifer, Lena Thin, Ashish Srinivasan et al.|UWA Profiles and Research Repository (University of Western Australia)|2019Cited by 3